11:30 am – 12:00 pm PDT Featured Featured When It Could Be Cystic Fibrosis (CF): Diagnosing CF in People with Atypical Disease Presentation
11:30 am – 12:30 pm PDT Featured Featured Clinical and patient-centered discussions on the role of inflammation in bronchiectasis
12:15 pm – 12:35 pm PDT Featured Featured Elevating Asthma Control: Implications for Your Pediatric Patients
1:15 pm – 2:00 pm PDT Featured Featured Pulmonary Alveolar Proteinosis: Pathophysiology, Diagnosis, and Management
11:30 am – 12:00 pm PDT Featured Featured Asthma Drivers of Disease: the effects of IL-5 on eosinophils and other cell types that contribute to airway remodeling and disease progression.
11:30 am – 12:30 pm PDT Featured Featured Interstitial Lung Disease: Presentation to Patient Experience
11:55 am – 12:15 pm PDT Featured Featured Earlier Assessment of Uncontrolled Moderate-to-Severe Asthma. Is There More We Can Do?
1:00 pm – 1:45 pm PDT Featured Featured Understanding the Pathophysiology and Burden of COPD With Blood Eosinophils as a Marker of T2 Inflammation – Is it the Time for Precision Medicine in COPD?
1:00 pm – 2:00 pm PDT Featured Featured Clinical Considerations for Sleep Specialists on the Improvement of Wakefulness in Patients With Excessive Daytime Sleepiness
6:30 pm – 7:30 pm PDT Featured Featured Type 2 Inflammation in the Pathophysiology of Asthma and COPD: What Is It and How Does It Impact Patients?
12:00 pm – 12:30 pm PDT Featured Featured Holistic Care of the Immunocompromised Pulmonary Patient with EGPA